RETIRED: Cancer and contraception
Authors:
- Ashlesha PatelAPAshlesha Patel
- E. Bimla SchwarzESE. Bimla Schwarz
- 1 September 2012
- journal article
- research article
- Published by Elsevier in Contraception
- Vol. 86 (3) , 191-198
Abstract
No abstract availableKeywords
This publication has 104 references indexed in Scilit:
- Contraception Methods, Beyond Oral Contraceptives and Tubal Ligation, and Risk of Ovarian CancerAnnals of Epidemiology, 2011
- Progesterone Receptor Induces ErbB-2 Nuclear Translocation To Promote Breast Cancer Growth via a Novel Transcriptional Effect: ErbB-2 Function as a Coactivator of Stat3Molecular and Cellular Biology, 2010
- Is progestin an independent risk factor for incident venous thromboembolism? A population-based case-control studyThrombosis Research, 2010
- Synthetic progestins induce growth and metastasis of BT-474 human breast cancer xenografts in nude miceMenopause, 2010
- Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: A meta-analysisEuropean Journal of Cancer, 2010
- Induced Abortions in Danish Cancer Survivors: A Population-Based Cohort StudyJNCI: Journal of the National Cancer Institute, 2009
- Use of oral contraceptives, intrauterine devices and tubal sterilization and cancer risk in a large prospective study, from 1996 to 2006International Journal of Cancer, 2009
- Oral contraceptives and the risk of all cancers combined and site-specific cancers in ShanghaiCancer Causes & Control, 2008
- A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virusAmerican Journal of Obstetrics and Gynecology, 2007
- Breast cancer in Hodgkin's disease and non-Hodgkin's lymphoma survivorsAnnals of Oncology, 2006